SCHEDULE 13G/A: StemPoint Capital Discloses 14.3% Stake in Surrozen, Inc. via Amended Schedule 13G Filing
Beneficial Ownership Report
StemPoint Capital LP, along with its affiliates, has reported a beneficial ownership of 14.3% in Surrozen, Inc., totaling 485,231 shares, as detailed in an amended Schedule 13G filing.
Summary
- StemPoint Capital LP, StemPoint Capital Management GP LLC, and Michelle Ross (collectively, the "Reporting Persons") have jointly filed an amended Schedule 13G.
- The filing reports their beneficial ownership in Surrozen, Inc.'s Common Stock, par value $0.0001 per share.
- As of December 31, 2024, the Reporting Persons beneficially own an aggregate of 485,231 shares of Surrozen, Inc.
- This ownership represents 14.3% of Surrozen, Inc.'s outstanding common stock.
- The total beneficial ownership includes 350,573 shares and 134,658 shares issuable upon the exercise of warrants.
- The percentage of class is calculated based on 3,249,798 shares outstanding as of November 4, 2024, as reported in the Issuer's quarterly report on Form 10-Q, plus the total number of shares the Reporting Persons have the right to acquire upon exercise of warrants.
- The Reporting Persons have shared voting power over 424,447 shares and shared dispositive power over 485,231 shares.
- The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer, other than activities solely in connection with a nomination under Rule 14a-11.
Sentiment
Score: 5
Explanation: The document is a factual disclosure of beneficial ownership and does not contain information that would inherently indicate positive or negative sentiment regarding the company's performance or outlook.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders: The disclosure of a significant institutional ownership stake (14.3%) by StemPoint Capital may influence investor perception and potentially signal confidence in Surrozen, Inc., or indicate potential future engagement by the investor.
Key Dates
| Date | Description |
|---|---|
| 11/04/2024 | Date as of which Surrozen, Inc.'s shares outstanding (3,249,798) were reported in its Form 10-Q. |
| 12/31/2024 | Date of event which requires filing of this statement (beneficial ownership as of year-end). |
| 02/14/2025 | Filing date of the Schedule 13G Amendment No. 1. |
Keywords
Surrozen Inc., StemPoint Capital, Schedule 13G, Beneficial Ownership, Common Stock, SEC Filing, Investment, Shareholding, Warrants, Institutional Investor
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.